Correction: ZHX2 Drives Cell Growth and Migration Via Activating MEK/ERK Signal and Induces Sunitinib Resistance by Regulating the Autophagy in Clear Cell Renal Cell Carcinoma

Zhu, Liangsong,Ding, Rong,Yan, Hao,Zhang, Jin,Lin, Zongming

DOI: https://doi.org/10.1038/s41419-021-03678-9

2021-01-01

Abstract:A Correction to this paper has been published: https://doi.org/10.1038/s41419-021-03678-9

What problem does this paper attempt to address?

ZHX2 Drives Cell Growth and Migration Via Activating MEK/ERK Signal and Induces Sunitinib Resistance by Regulating the Autophagy in Clear Cell Renal Cell Carcinoma (vol 11, 337, 2020)

Liangsong Zhu,Rong Ding,Hao Yan,Jin Zhang,Zongming Lin

DOI: https://doi.org/10.1038/s41419-021-03678-9

2021-01-01

Abstract:A Correction to this paper has been published: https://doi.org/10.1038/s41419-021-03678-9
Correction: PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder Through Sponging Mir-30C to Induce Epithelial–Mesenchymal Transition

Xin Chen,Rixin Chen,Wensu Wei,Yonghong Li,Zhaoyong Feng,Liang Tan,Jie-Wei Chen,Yuan Gang,Siliang Chen,Shengjie Guo,Kai Xiao,Zhuowei Liu,Junhang Luo,Fangjian Zhou,Dan Xie

DOI: https://doi.org/10.1158/1078-0432.ccr-21-0936

IF: 13.801

2021-01-01

Clinical Cancer Research

Abstract:In the original version of [this article][1] ([1][2]), an incorrect image was used for the p-control cells in Fig. 2F. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret the error. 1. 1.[↵][3]1. Chen X, 2. Chen R-X, 3. Wei W-S
ZHX2 Drives Cell Growth and Migration Via Activating MEK/ERK Signal and Induces Sunitinib Resistance by Regulating the Autophagy in Clear Cell Renal Cell Carcinoma

Liangsong Zhu,Rong Ding,Hao Yan,Jin Zhang,Zongming Lin

DOI: https://doi.org/10.1038/s41419-020-2541-x

2020-01-01

Abstract:Zinc fingers and homeoboxes 2 (ZHX2) was found as a novel VHL substrate target, and acted as an oncogenic driver in ccRCC. However, the detailed mechanism of ZHX2 in ccRCC development remains elusive, and no research has focused on studying ZHX2 in drug resistance yet. A tissue microarray with 358 ccRCC samples was used to determine the expression of ZHX2 in ccRCC patients. VHL-deficient cell line 786-O and VHL-normal cell line CAKI-1 was used for lineage reprogramming by transfecting with lentivirus. The in vitro and in vivo experiments were performed with these new cell lines to determine the mechanism of ZHX2 in ccRCC development and drug resistance. Immunohistochemistry analysis showed that ZHX2 was not highly expressed in ccRCC tumor tissues, only 33.2% (119/358) patients have high ZHX2 expression. However, high ZHX2 was significantly associated with advanced Fuhrman grade (p=0.004), and proved to be an independent prognosis factor for progression-free survival (p=0.0003), while there is no significant correlation with overall survival. We further discovered that ZHX2 overexpression could increase VEGF secretion and transcriptional activate the MEK/ERK1/2 and promote its downstream targets. We also found ZHX2 overexpression induce Sunitinib resistance though activating autophagy and the combination treatment of Sunitinib and Chloroquine could significantly rescue the phenomenon. In summary, these results indicate that ZHX2 drivers cell growth, migration though increase VEGF expression, and transcriptional activate MEK/ERK1/2 signaling pathway, and could induce Sunitinib resistance by regulating self-protective autophagy, these may provide new insight in advanced ccRCC treatment.
Correction To: KIF5B-RET Fusion Kinase Promotes Cell Growth by Multilevel Activation of STAT3 in Lung Cancer

Yingying Qian,Shoujie Chai,Zuyu Liang,Yongfang Wang,You Zhou,Xia Xu,Chenchen Zhang,Min Zhang,Jingxing Si,Feiteng Huang,Zhangdan Huang,Wei Hong,Kai Wang

DOI: https://doi.org/10.1186/s12943-019-1093-0

IF: 37.3

2019-01-01

Molecular Cancer

Abstract:After the publication of this work [1],
Correction: Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells

Guoxi Zhang,Junrong Zou,Jinglin Shi,Biao Qian,Kaiyang Qiu,Quanliang Liu,Tianpeng Xie,Zhihua He,Hui Xu,Yunfeng Liao,Yuting Wu,Yanmin Li,Guancheng Xiao,Yuanhu Yuan,Rihai Xiao,Gengqing Wu,Xiaofeng Zou

DOI: https://doi.org/10.1038/s41419-023-06384-w

2024-01-04

Cell Death and Disease

Abstract:Cell Death & Disease, Published online: 03 January 2024; doi:10.1038/s41419-023-06384-w Correction: Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells

cell biology
Correction to: NUPR1 promotes the proliferation and metastasis of oral squamous cell carcinoma cells by activating TFE3-dependent autophagy

Tengfei Fan,Xiaoning Wang,Sheng Zhang,Ping Deng,Yi Jiang,Yidan Liang,Sheng Jie,Qing Wang,Chuwen Li,Guocai Tian,Zhen Zhang,Zhenhu Ren,Bo Li,Yanrong Chen,Zhijing He,Yan Luo,Mingliang Chen,Hanjiang Wu,Zhengping Yu,Huifeng Pi,Zhou Zhou,Zhiyuan Zhang

DOI: https://doi.org/10.1038/s41392-022-01154-0

IF: 39.3

2022-09-18

Signal Transduction and Targeted Therapy

Abstract:Signal Transduction and Targeted Therapy, Published online: 16 September 2022; doi:10.1038/s41392-022-01154-0 Correction to: NUPR1 promotes the proliferation and metastasis of oral squamous cell carcinoma cells by activating TFE3-dependent autophagy

biochemistry & molecular biology,cell biology
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum

Libin Yan,Beichen Ding,Haoran Liu,Yangjun Zhang,Jin Zeng,Junhui Hu,Weimin Yao,Gan Yu,Ruihua An,Zhiqiang Chen,Zhangqun Ye,Jinchun Xing,Kefeng Xiao,Lily Wu,Hua Xu

DOI: https://doi.org/10.7150/thno.68810

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.37628.].

medicine, research & experimental
Correction to: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling

Weiwei Sheng,Xiaoyang Shi,Yiheng Lin,Jingtong Tang,Chao Jia,Rongxian Cao,Jian Sun,Guosen Wang,Lei Zhou,Ming Dong

DOI: https://doi.org/10.1186/s13046-020-01663-2

2020-08-24

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Correction to: Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma

Yan Chen,Zhonghu Li,Mengyun Zhang,Bo Wang,Jiaxin Ye,Yang Zhang,Di Tang,Dandan Ma,Weidong Jin,Xiaowu Li,Shuguang Wang

DOI: https://doi.org/10.1186/s13046-021-01902-0

2021-04-16

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Correction to: CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p

Lu Wang,Guang Yang,Danfeng Zhao,Jiaqi Wang,Yang Bai,Qiang Peng,Hongzhi Wang,Ruizhe Fang,Guang Chen,Zhichao Wang,Keliang Wang,Guangbin Li,Yinhui Yang,Ziqi Wang,Pengyu Guo,Li Peng,Dayong Hou,Wanhai Xu

DOI: https://doi.org/10.1186/s12943-020-01261-y

IF: 37.3

2020-09-24

Molecular Cancer

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology,biochemistry & molecular biology
Correction: PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3

Zhipeng Gao,Xiaojun Man,Zhenhua Li,Jianbin Bi,Xiankui Liu,Zeliang Li,Jun Li,Zhe Zhang,Chuize Kong

DOI: https://doi.org/10.1038/s41417-022-00458-1

IF: 5.854

2022-03-31

Cancer Gene Therapy

Abstract:Cancer Gene Therapy, Published online: 31 March 2022; doi:10.1038/s41417-022-00458-1Correction: PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3

oncology,genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology
Correction: GATA3 suppresses human fibroblasts-induced metastasis of clear cell renal cell carcinoma via an anti-IL6/STAT3 mechanism

Qianqian Shi,Renfang Xu,Guanglai Song,Hao Lu,Dong Xue,Xiaozhou He,Ying Xia

DOI: https://doi.org/10.1038/s41417-020-00229-w

IF: 5.854

2020-11-06

Cancer Gene Therapy

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

oncology,genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology
Corrigendum: Downregulation of HMGA1 Mediates Autophagy and Inhibits Migration and Invasion in Bladder Cancer via miRNA-221/TP53INP1/p-ERK Axis

Xiaoqiang Liu,Zhengtao Zhou,Yibing Wang,Ke Zhu,Wen Deng,Yulei Li,Xiaochen Zhou,Luyao Chen,Yu Li,An Xie,Tao Zeng,Gongxian Wang,Bin Fu

DOI: https://doi.org/10.3389/fonc.2020.01735

IF: 4.7

2020-09-04

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.00589.].

oncology
Activation of the PI3K/Akt/mTOR/p70S6K Pathway is Involved in S100A4-Induced Viability and Migration in Colorectal Cancer Cells: Erratum

Haiyan Wang,Liang Duan,Zhengyu Zou,Huan Li,Shimei Yuan,Xian Chen,Yunyuan Zhang,Xueru Li,Hui Sun,He Zha,Yan Zhang,Lan Zhou

DOI: https://doi.org/10.7150/ijms.69070

2022-01-01

International Journal of Medical Sciences

Abstract:[This corrects the article DOI: 10.7150/ijms.8128.].

medicine, general & internal
Correction: CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism

Zhen Zhang,Jianjun Li,Yang Ou,Guang Yang,Kaiyuan Deng,Qiong Wang,Zhaoyang Wang,Wenhao Wang,Quansheng Zhang,Hang Wang,Wei Sun,Peiqing Sun,Shuang Yang

DOI: https://doi.org/10.1038/s41392-024-01972-4

IF: 39.3

2024-10-05

Signal Transduction and Targeted Therapy

Abstract:Signal Transduction and Targeted Therapy, Published online: 04 October 2024; doi:10.1038/s41392-024-01972-4 Correction: CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism

biochemistry & molecular biology,cell biology
Correction: Clinical Significance and Effect of AEG-1 on the Proliferation, Invasion, and Migration of NSCLC: a Study Based on Immunohistochemistry, TCGA, Bioinformatics, in Vitro and in Vivo Verification.

Yu Zhang,Zu-Yun Li,Xin-Xi Hou,Xiao Wang,Yi-Huan Luo,Yan-Ping Ying,Gang Chen

DOI: https://doi.org/10.18632/oncotarget.28212

2022-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14972.].
Correction: Cao et al. Tubeimoside-1 Inhibits Glioblastoma Growth, Migration, and Invasion via Inducing Ubiquitylation of MET. Cells 2019, 8, 774

Jiangjun Cao,Erhu Zhao,Qingzong Zhu,Juanli Ji,Zekun Wei,Bo Xu,Hongjuan Cui

DOI: https://doi.org/10.3390/cells13181577

IF: 6

2024-09-20

Cells

Abstract:Cells, Vol. 13, Pages 1577: Correction: Cao et al. Tubeimoside-1 Inhibits Glioblastoma Growth, Migration, and Invasion via Inducing Ubiquitylation of MET. Cells 2019, 8, 774 Cells doi: 10.3390/cells13181577 Authors: Jiangjun Cao Erhu Zhao Qingzong Zhu Juanli Ji Zekun Wei Bo Xu Hongjuan Cui In the Correspondence information of the original publication [...]

cell biology
Correction to: Inactivation of the Wnt/β-catenin signaling pathway underlies inhibitory role of microRNA-129-5p in epithelial–mesenchymal transition and angiogenesis of prostate cancer by targeting ZIC2

Zhenming Jiang,Yuxi Zhang,Xi Chen,Pingeng Wu,Dong Chen

DOI: https://doi.org/10.1186/s12935-021-01945-5

IF: 6.429

2021-04-26

Cancer Cell International

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Correction: Lertsuwan et al. CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism. Cancers 2018, 10, 283

Jomnarong Lertsuwan,Kornkamon Lertsuwan,Anyaporn Sawasdichai,Nathapol Tasnawijitwong,Ka Ying Lee,Philip Kitchen,Simon Afford,Kevin Gaston,Padma-Sheela Jayaraman,Jutamaad Satayavivad

DOI: https://doi.org/10.3390/cancers15010133

2022-12-26

Abstract:Authors would like to make a correction to the previous article [...].
Erratum: Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma.

Xiwei Ding,Yiyang Zhang,Tianlu Huang,Guifang Xu,Chunyan Peng,Gang Chen,Bo Kong,Helmut Friess,Shanshan Shen,Ying Lv,Lewis R Roberts,Lei Wang,Xiaoping Zou

2023-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 546 in vol. 9, PMID: 30949409.].

Correction: ZHX2 Drives Cell Growth and Migration Via Activating MEK/ERK Signal and Induces Sunitinib Resistance by Regulating the Autophagy in Clear Cell Renal Cell Carcinoma

ZHX2 Drives Cell Growth and Migration Via Activating MEK/ERK Signal and Induces Sunitinib Resistance by Regulating the Autophagy in Clear Cell Renal Cell Carcinoma (vol 11, 337, 2020)

Correction: PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder Through Sponging Mir-30C to Induce Epithelial–Mesenchymal Transition

ZHX2 Drives Cell Growth and Migration Via Activating MEK/ERK Signal and Induces Sunitinib Resistance by Regulating the Autophagy in Clear Cell Renal Cell Carcinoma

Correction To: KIF5B-RET Fusion Kinase Promotes Cell Growth by Multilevel Activation of STAT3 in Lung Cancer

Correction: Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells

Correction to: NUPR1 promotes the proliferation and metastasis of oral squamous cell carcinoma cells by activating TFE3-dependent autophagy

Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum

Correction to: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling

Correction to: Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma

Correction to: CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p

Correction: PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3

Correction: GATA3 suppresses human fibroblasts-induced metastasis of clear cell renal cell carcinoma via an anti-IL6/STAT3 mechanism

Corrigendum: Downregulation of HMGA1 Mediates Autophagy and Inhibits Migration and Invasion in Bladder Cancer via miRNA-221/TP53INP1/p-ERK Axis

Activation of the PI3K/Akt/mTOR/p70S6K Pathway is Involved in S100A4-Induced Viability and Migration in Colorectal Cancer Cells: Erratum

Correction: CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism

Correction: Clinical Significance and Effect of AEG-1 on the Proliferation, Invasion, and Migration of NSCLC: a Study Based on Immunohistochemistry, TCGA, Bioinformatics, in Vitro and in Vivo Verification.

Correction: Cao et al. Tubeimoside-1 Inhibits Glioblastoma Growth, Migration, and Invasion via Inducing Ubiquitylation of MET. Cells 2019, 8, 774

Correction to: Inactivation of the Wnt/β-catenin signaling pathway underlies inhibitory role of microRNA-129-5p in epithelial–mesenchymal transition and angiogenesis of prostate cancer by targeting ZIC2

Correction: Lertsuwan et al. CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism. Cancers 2018, 10, 283

Erratum: Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma.